DOLGIT

This brand name is authorized in Austria, Croatia, Estonia, Germany, Lithuania, Poland, Tunisia, Turkey.

Active ingredients

The drug DOLGIT contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M02AA13	Ibuprofen	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02363273, 02363333, 03030674, 03030680, 03834711, 03834728, 08541801, 08544484, 08544774, 08556004, 10315822, 10343238
EE	Ravimiamet	1019933, 1073955
HR	Agencija za lijekove i medicinske proizvode	HR-H-107809398, HR-H-241728003
LT	Valstybinė vaistų kontrolės tarnyba	1006492
PL	Rejestru Produktów Leczniczych	100030191, 100247275
TN	Direction de la Pharmacie et du Médicament	3183061
TR	İlaç ve Tıbbi Cihaz Kurumu	8699587192592, 8699587192608, 8699587351661